Donaldson Capital Management LLC trimmed its stake in shares of Huntington Bancshares Incorporated (NASDAQ:HBAN – Free Report) by 4.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 60,582 shares of the bank’s stock after selling 2,850 shares during the period. Donaldson Capital Management LLC’s holdings in Huntington Bancshares were worth $891,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Robeco Institutional Asset Management B.V. lifted its stake in shares of Huntington Bancshares by 40.7% in the third quarter. Robeco Institutional Asset Management B.V. now owns 192,984 shares of the bank’s stock worth $2,837,000 after buying an additional 55,865 shares in the last quarter. Fort Pitt Capital Group LLC purchased a new position in Huntington Bancshares during the third quarter worth about $454,000. Confluence Wealth Services Inc. increased its position in shares of Huntington Bancshares by 14.7% during the third quarter. Confluence Wealth Services Inc. now owns 31,048 shares of the bank’s stock valued at $456,000 after acquiring an additional 3,988 shares during the last quarter. Chicago Partners Investment Group LLC acquired a new stake in shares of Huntington Bancshares during the third quarter valued at about $180,000. Finally, Farther Finance Advisors LLC increased its position in shares of Huntington Bancshares by 19.3% during the third quarter. Farther Finance Advisors LLC now owns 11,618 shares of the bank’s stock valued at $171,000 after acquiring an additional 1,883 shares during the last quarter. 80.72% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of research analysts recently weighed in on the stock. Barclays lifted their price objective on shares of Huntington Bancshares from $15.00 to $17.00 and gave the company an “equal weight” rating in a report on Friday, October 18th. Argus boosted their price objective on shares of Huntington Bancshares from $15.00 to $16.00 and gave the stock a “buy” rating in a research report on Monday, July 22nd. Citigroup boosted their price objective on shares of Huntington Bancshares from $17.00 to $18.00 and gave the stock a “buy” rating in a research report on Monday, July 22nd. Evercore ISI upped their price target on shares of Huntington Bancshares from $17.00 to $18.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. Finally, Morgan Stanley upped their price target on shares of Huntington Bancshares from $16.00 to $18.00 and gave the company an “overweight” rating in a research report on Monday, August 5th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $16.09.
Insider Activity at Huntington Bancshares
In other Huntington Bancshares news, insider Helga Houston sold 6,455 shares of the firm’s stock in a transaction dated Wednesday, October 23rd. The shares were sold at an average price of $15.43, for a total transaction of $99,600.65. Following the completion of the transaction, the insider now directly owns 558,342 shares in the company, valued at approximately $8,615,217.06. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.89% of the stock is owned by corporate insiders.
Huntington Bancshares Stock Performance
NASDAQ:HBAN opened at $15.40 on Tuesday. The company has a quick ratio of 0.87, a current ratio of 0.88 and a debt-to-equity ratio of 0.86. Huntington Bancshares Incorporated has a fifty-two week low of $10.10 and a fifty-two week high of $16.03. The stock has a market cap of $22.37 billion, a PE ratio of 14.81, a price-to-earnings-growth ratio of 3.18 and a beta of 1.03. The firm’s fifty day simple moving average is $14.90 and its 200-day simple moving average is $14.08.
Huntington Bancshares (NASDAQ:HBAN – Get Free Report) last posted its quarterly earnings results on Thursday, October 17th. The bank reported $0.33 earnings per share for the quarter, topping analysts’ consensus estimates of $0.30 by $0.03. Huntington Bancshares had a net margin of 14.19% and a return on equity of 10.72%. The business had revenue of $1.89 billion for the quarter, compared to analysts’ expectations of $1.86 billion. During the same period in the prior year, the company posted $0.36 EPS. Analysts expect that Huntington Bancshares Incorporated will post 1.2 earnings per share for the current fiscal year.
Huntington Bancshares Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Thursday, January 2nd. Stockholders of record on Wednesday, December 18th will be paid a dividend of $0.155 per share. The ex-dividend date is Wednesday, December 18th. This represents a $0.62 dividend on an annualized basis and a dividend yield of 4.03%. Huntington Bancshares’s dividend payout ratio (DPR) is presently 59.62%.
Huntington Bancshares Profile
Huntington Bancshares Incorporated operates as the bank holding company for The Huntington National Bank that provides commercial, consumer, and mortgage banking services in the United States. The company offers financial products and services to consumer and business customers, including deposits, lending, payments, mortgage banking, dealer financing, investment management, trust, brokerage, insurance, and other financial products and services.
See Also
- Five stocks we like better than Huntington Bancshares
- 10 Best Airline Stocks to Buy
- Intel: Is Now the Time to Be Brave?
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Most active stocks: Dollar volume vs share volume
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Want to see what other hedge funds are holding HBAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Huntington Bancshares Incorporated (NASDAQ:HBAN – Free Report).
Receive News & Ratings for Huntington Bancshares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Huntington Bancshares and related companies with MarketBeat.com's FREE daily email newsletter.